Journey Medical Corporation (DERM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 188.88M |
| Enterprise Value | 190.19M |
| P/E Ratio | -34.31 |
| PEG Ratio | -1.63 |
| Price/Sales Ratio | 3.13 |
| Price/Book Ratio | 6.63 |
| Enterprise/Revenue | 3.13 |
| Enterprise/EBITDA | 115.3 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.09 |
| Operating Margin | -0.04 |
| Return On Assets | -0.06 |
| Return On Equity | -0.2 |
| Revenue | 61.86M |
| Revenue/Share | 2.48 |
| Gross Profit | 36.68M |
| EBITDA | -3.33M |
| Net Income | -11.43M |
| Diluted EPS | -0.47 |
| Total Cash | 25.64M |
| Total Cash/Share | 0.93 |
| Total Debt | 25.54M |
| Total Debt/Equity | 0.8 |
| Current Ratio | 1.59 |
| Book Value Per Share | 1.17 |
| 52-Week Change | 4.73 |
| 52-Week High | 9.56 |
| 52-Week Low | 4.31 |
| Moving Average 50 Days | 6.68 |
| Moving Average 200 Days | 6.99 |
| Average Volume | 255,759 |
| Shares Outstanding | 27.52M |
| % Held by Institutions | 39.23 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |